IgA Vasculitis Market: How Are Biologic Therapies Reshaping...

agregó una foto Health

2026-06-26 10:32:31 -

IgA Vasculitis Market: How Are Biologic Therapies Reshaping Treatment for This Pediatric-Dominant Systemic Vasculitis?

IgA vasculitis (formerly Henoch-Schönlein purpura) — the most common systemic vasculitis in children affecting approximately 10-20 per 100,000 annually, with up to 50% of patients experiencing persistent renal involvement requiring long-term immunosuppression — creates the most clinically dynamic segment in the broader vasculitis treatment landscape, with the Immunoglobulin A...

0 Commentarios 0 Acciones 6 Views 0 Vista previa